Compare Amphastar Pharmaceuticals Inc (AMPH) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Alphabet Inc Class A — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Alphabet Inc Class A trades at $345.83 (market cap $4.20T). The key difference: Alphabet Inc Class A is far larger — about 4835.3× Amphastar Pharmaceuticals Inc's market cap, and Alphabet Inc Class A pays a 0.26% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | GOOGL | |
|---|---|---|
Market Cap | $868.62M | $4.20T |
Sector | Health | Media |
52-Week High | $30.81 | $402.62 |
52-Week Low | $16.87 | $199.32 |
Enterprise Value | $1.27B | $4.09T |
Dividend Yield | — | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Alphabet (GOOGL) trades at $357.52, up 0.91% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $9.11 versus $2.87 forecast. Revenue grew to $402.84 billion in 2025 with net income margin expanding to 32.8%. Recent developments include YouTube subscription price increases and AI infrastructure partnerships.
Alphabet presents a compelling investment case with strong earnings momentum and dominant market position. The primary opportunity lies in AI-driven growth and cloud expansion, though risks include antitrust scrutiny and competitive pressures. With 85% analyst buy ratings and a $426.28 consensus target representing 19% upside, the stock offers attractive potential despite regulatory headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
